AHRQ To Compare Treatments For Women With Coronary Artery Disease
This article was originally published in The Gray Sheet
Executive Summary
The Agency for Healthcare Research and Quality is seeking feedback on questions it will use to learn how women respond to various treatments for coronary artery disease
You may also be interested in...
AHRQ, NIH Report To Congress On Comparative Effectiveness Spending Plans
Two Health and Human Services agencies will allocate about $250 million this year in comparative effectiveness research funds from the federal stimulus package; the remainder of the $1.1 billion comparative effectiveness money will be put to use in 2010
PCI And Bypass Surgery Outcomes Similar; Data Lacking On Subgroups – AHRQ
Outcomes from opening clogged coronary arteries with angioplasty and bypass surgery are similar overall, a draft report from the Agency for Healthcare Research and Quality suggests, but data is lacking on the best option for many specific patient subgroups
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”